ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ZVRA on Nasdaq
Shares outstanding
56,066,823
Price per share
$8.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
39,900,311
Total reported value
$379,437,218
% of total 13F portfolios
0%
Share change
+3,632,578
Value change
+$36,778,994
Number of holders
162
Price from insider filings
$8.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.6% $29,501,437 4,080,420 BlackRock, Inc. 31 Dec 2024
Woodline Partners LP 6.2% $33,058,120 3,476,143 Woodline Partners LP 30 Sep 2025
Nantahala Capital Management, LLC 4.4% -20% $16,920,608 -$4,220,064 2,340,333 -20% Nantahala Capital Management, LLC 31 Dec 2024
Adage Capital Management, L.P. 4% -41% $21,159,750 -$13,551,750 2,225,000 -39% Adage Capital Management, L.P. 30 Sep 2025

As of 30 Sep 2025, 162 institutional investors reported holding 39,900,311 shares of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA). This represents 71% of the company’s total 56,066,823 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.2% 4,037,154 -1.1% 0% $38,393,334
Woodline Partners LP 6.2% 3,476,143 -25% 0.16% $33,058,120
VANGUARD GROUP INC 5.5% 3,083,362 +4.4% 0% $29,322,773
ADAGE CAPITAL PARTNERS GP, L.L.C. 4% 2,225,000 -47% 0.03% $21,159,750
Nantahala Capital Management, LLC 3.5% 1,971,936 +34% 1.2% $18,753,112
FMR LLC 2.9% 1,634,571 -29% 0% $15,544,766
STATE STREET CORP 2.5% 1,427,291 +15% 0% $13,573,537
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,300,340 +4.7% 0% $12,368,921
AIGH Capital Management LLC 2.2% 1,231,932 +34% 4.1% $11,715,673
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.2% 1,205,514 +646% 0.02% $11,464,438
Legal & General Group Plc 1.9% 1,053,399 +13% 0% $10,017,824
MILLENNIUM MANAGEMENT LLC 1.8% 1,035,251 +63% 0.01% $9,845,237
683 Capital Management, LLC 1.7% 975,000 -13% 0.84% $9,272,250
MARSHALL WACE, LLP 1.6% 912,299 0.01% $8,675,963
Stonepine Capital Management, LLC 1.4% 810,000 +4.4% 6.3% $7,703,100
GOLDMAN SACHS GROUP INC 1.4% 761,777 +103% 0% $7,244,500
D. E. Shaw & Co., Inc. 1.3% 725,830 +283% 0.01% $6,902,644
ROYCE & ASSOCIATES LP 1.2% 691,239 0.07% $6,573,683
KINGDON CAPITAL MANAGEMENT, L.L.C. 1.2% 650,000 +44% 0.97% $6,181,500
Retirement Planning Co of New England, Inc. 1.1% 600,770 +8.6% 2.3% $5,713,323
MORGAN STANLEY 0.99% 555,950 +161% 0% $5,287,085
Caption Management, LLC 0.91% 510,091 0.28% $4,850,965
TUDOR INVESTMENT CORP ET AL 0.8% 447,896 0.03% $4,259,491
NORTHERN TRUST CORP 0.78% 439,480 +3.4% 0% $4,179,455
JPMORGAN CHASE & CO 0.78% 438,984 +1459% 0% $4,174,739

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 606,368 $5,432,902 +$2,986,138 $8.96 12
2025 Q3 39,900,311 $379,437,218 +$36,778,994 $9.51 162
2025 Q2 36,165,830 $318,624,169 +$9,847,978 $8.81 119
2025 Q1 35,351,805 $264,779,873 +$11,437,756 $7.49 109
2024 Q4 33,925,967 $282,929,757 +$43,767,647 $8.34 108
2024 Q3 28,925,387 $200,746,422 +$88,219,086 $6.94 105
2024 Q2 16,043,055 $78,561,424 +$9,453,621 $4.90 92
2024 Q1 13,910,496 $80,679,510 +$7,031,758 $5.80 88
2023 Q4 12,678,435 $83,043,757 +$12,292,891 $6.55 83
2023 Q3 10,800,557 $52,059,801 +$12,731,917 $4.82 76
2023 Q2 8,153,478 $41,582,121 +$9,633,583 $5.10 69
2023 Q1 6,153,233 $33,836,990 +$3,326,482 $5.50 59
2022 Q4 5,912,306 $27,146,724 -$3,423,716 $4.59 66
2022 Q3 6,683,041 $41,695,480 -$3,025,737 $6.24 63
2022 Q2 7,231,996 $32,280,920 -$8,047,771 $4.46 61
2022 Q1 8,999,997 $45,269,137 +$8,091,446 $5.03 72
2021 Q4 7,241,315 $62,973,380 -$7,065,660 $8.71 72
2021 Q3 7,785,907 $72,596,741 -$2,908,464 $9.33 65
2021 Q2 7,669,356 $98,321,566 +$70,526,213 $12.82 66
2021 Q1 2,343,772 $21,986,514 +$21,240,741 $9.20 46
2020 Q4 1,660 $19,000 +$14,000 $11.70 2
2020 Q3 410 $5,000 $12.20 1
2020 Q2 410 $5,000 $12.20 1
2020 Q1 410 $5,000 $12.20 1
2019 Q4 410 $5,000 $12.20 1
2019 Q3 410 $5,000 $12.20 1
2019 Q2 410 $5,000 $12.20 1
2019 Q1 410 $5,000 $12.20 1